http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003525629-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2482 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L7-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2001-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003525629-A |
| titleOfInvention | Xylanase variants with altered sensitivity to xylanase inhibitors |
| abstract | (57) [Summary]nThe present invention relates to modified xylanase polypeptides or fragments thereof having xylanase activity. The polypeptide or variant thereof comprises one or more amino acid modifications such that the polypeptide or variant thereof has an altered sensitivity to the xylanase inhibitor as compared to the parent enzyme. The present invention is a variant xylanase polypeptide comprising one or more amino acid alterations, or a fragment thereof having xylanase activity, wherein said alteration results in altered susceptibility to a xylanase inhibitor as compared to a parent xylanase enzyme. , Polypeptides or fragments thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012513206-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012513207-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015146812-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015163070-A |
| priorityDate | 2000-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 539.